Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
As in humans, obesity in animals can trigger serious health problems such as diabetes , heart disease or joint disease
Retatrutide , developed by Eli Lilly, is a novel triple agonist that simultaneously activates three receptors: GLP-1 (glucagon-like peptide-1) receptor reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin secretion
Retatrutide improves insulin sensitivity through GLP-1 and GIP receptor activation
It's a naturally occurring copper peptide that activates genes responsible for collagen synthesis, elastin production, antioxidant defense, and tissue repair
US$ 24.56
US$ 27.27
US$ 20.11
US$ 24.72
US$ 24.85
